Geoffrey K. Broadhead - Publications

Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study.

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Published: December 17, 2025

Towards Accountable AI in Eye Disease Diagnosis: Workflow, External Validation, and Development.

Journal: ArXiv

Published: September 19, 2025

Trans-scleral cryotherapy in the management of retinal hemangioblastomas.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: August 04, 2025

AI Workflow, External Validation, and Development in Eye Disease Diagnosis.

Journal: JAMA network open

Published: July 16, 2025

A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN Study.

Journal: BMJ open ophthalmology

Published: June 02, 2025

Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences.

Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Published: April 23, 2025

How to Judge Failure: Defining Treatment Resistance to Anti-VEGF Therapy in Exudative Maculopathies-A Systematic Scoping Review.

Journal: Ophthalmology. Retina

Published: April 20, 2025

Injections in the back of the eye: The why, the what and when to worry.

Journal: Australian journal of general practice

Published: July 03, 2024

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis.

Journal: Clinical & experimental ophthalmology

Published: April 10, 2024

Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment.

Journal: Ophthalmology science

Published: September 28, 2023

Saffron therapy for the ongoing treatment of age-related macular degeneration.

Journal: BMJ open ophthalmology

Published: July 17, 2023

Translating discoveries as novel biomarkers and interventions in ophthalmology.

Journal: Journal of translational medicine

Published: June 13, 2023